Silo Pharma announces partnership with CRO for small animal study of SPU-16
PremiumThe FlySilo Pharma announces partnership with CRO for small animal study of SPU-16
3M ago
Silo Pharma to present on SPC-15 at H.C. Wainwright conference
Premium
The Fly
Silo Pharma to present on SPC-15 at H.C. Wainwright conference
3M ago
Silo Pharma to sell 763,638 shares at $2.75 in registered direct offering
Premium
The Fly
Silo Pharma to sell 763,638 shares at $2.75 in registered direct offering
4M ago
Silo announces exclusive, global license for SPC-15 with Columbia University
PremiumThe FlySilo announces exclusive, global license for SPC-15 with Columbia University
4M ago
Silo Pharma, AmplifyBio partner to advance SPC-15 for PTSD, anxiety
Premium
The Fly
Silo Pharma, AmplifyBio partner to advance SPC-15 for PTSD, anxiety
4M ago
Silo Pharma announces successful production of its SP-26 ketamine implant
Premium
The Fly
Silo Pharma announces successful production of its SP-26 ketamine implant
5M ago
Silo Pharma announces results for intranasal PTSD treatment
PremiumThe FlySilo Pharma announces results for intranasal PTSD treatment
7M ago
Silo Pharma exercises option to license SPC-14 from Columbia University
Premium
The Fly
Silo Pharma exercises option to license SPC-14 from Columbia University
7M ago
Silo Pharma exercises options for exclusive license agreement
Premium
The Fly
Silo Pharma exercises options for exclusive license agreement
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100